NCM
AUTL
Nantahala Capital Management’s Autolus Therapeutics AUTL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-4,272,203
| Closed | -$10.2M | – | 114 |
|
|
2023
Q2 | $10.2M | Sell |
4,272,203
-3,419,610
| -44% | -$8.14M | 0.98% | 23 |
|
|
2023
Q1 | $14.2M | Sell |
7,691,813
-90,205
| -1% | -$166K | 1.08% | 23 |
|
|
2022
Q4 | $14.8M | Buy |
7,782,018
+2,566,230
| +49% | +$4.88M | 0.96% | 23 |
|
|
2022
Q3 | $11.2M | Buy |
5,215,788
+72,933
| +1% | +$156K | 0.72% | 29 |
|
|
2022
Q2 | $14.6M | Buy |
5,142,855
+796,528
| +18% | +$2.25M | 0.73% | 25 |
|
|
2022
Q1 | $18.1M | Buy |
4,346,327
+268,818
| +7% | +$1.12M | 0.8% | 24 |
|
|
2021
Q4 | $21.2M | Buy |
4,077,509
+1,140,718
| +39% | +$5.92M | 0.74% | 25 |
|
|
2021
Q3 | $19.2M | Buy |
2,936,791
+1,143,291
| +64% | +$7.49M | 0.61% | 28 |
|
|
2021
Q2 | $11.9M | Buy |
+1,793,500
| New | +$11.9M | 0.34% | 45 |
|